Autosomal recessive epidermolysis bullosa simplex. A case report

Epidermolysis Bullosa: Two rare case reports of COL7A1 and EBS-GEN SEV KRT14 variants with review of literature

EPIDERMOLYSIS

Bullosa is a rare hereditary skin condition that causes blisters. Genes encoding structural proteins at or near the dermal-epidermal junction are mutated recessively or dominantly, and this is the primary cause of EB. Herein, two Chinese boys were diagnosed with the condition, each with a different variant in a gene that serves as a reference for EB genetic counseling. Skincare significantly impacted their prognosis and quality of life.

CASE PRESENTATION

Two Chinese boys, with phenotypically normal parents, have been diagnosed with distinct blister symptoms, one with Dominant Dystrophic Epidermolysis Bullosa and the other with a severe form of Epidermolysis Bullosa Simplex. The first patient had a G-to-A variant in the COL7A1 allele, at nucleotide position 6163 which was named "G2055A". The proband is heterozygous for Dystrophic Epidermolysis Bullosa due to a COL7A1 allele with a glycine substitution at the triple helix domain. A similar variant has been discovered in his mother, indicating its potential transmission to future generations. Another patient had severe Epidermolysis Bullosa Simplex with a rare c.377T > A  variant resulting in substitution of amino acid p.Leu126Arg (NM_000526.5 (c.377T > G, p.Leu126Arg) in the Keratin 14 gene. In prior literature, Keratin 14 has been associated with an excellent prognosis. However, our patient with this infrequent variant tragically died from sepsis at 21 days old. There has been a reported occurrence of the variant only once.

CONCLUSION

Our study reveals that Epidermolysis Bullosa patients with COL7A1 c.6163G > A and KRT14 c.377T>A variants have different clinical presentations, with dominant forms of Dystrophic EB having milder phenotypes than recessive ones. Thus, the better prognosis in the c.6163G > A patient. Furthermore, c.377T>A patient was more prone to infection than the patient with c.6163G>A gene variant. Genetic testing is crucial for identifying the specific variant responsible and improving treatment options.

Ultrastructural differentiation of epidermolysis bullosa subtypes and porphyria cutanea tarda

Identifying subtypes of epidermolysis bullosa clinically, particularly at the time of disease onset, can be extremely difficult. In this investigation samples of intact skin from cases of epidermolysis bullosa and porphyria cutanea tarda were examined ultrastructurally and compared with normal tissue. The histological composition of the blister roof and floor surfaces was also evaluated. Three of the ten epidermolysis bullosa subtypes examined revealed specific features. Distinctive, circumscribed, clumped tonofilament bodies were present in basal keratinocytes from epidermolysis bullosa herpetiformis Dowling-Meara. Blister formation in epidermolysis bullosa simplex generalisata gravis occurred immediately above the dermo-epidermal junction aspect of stratum basale cells and thick (30 nm diameter), cross-striated anchoring fibrils were absent in epidermolysis bullosa dystrophica generalisata gravis. Features relating to the lamina densa of the dermo-epidermal junction, dermal capillaries and blister composition were distinctive, but not confined to a particular epidermolysis bullosa subtype or porphyria cutanea tarda.

Management of patients with epidermolysis bullosa

Epidermolysis bullosa is a group of systemic disorders whose management requires familiarity with its many extracutaneous complications. These include gastrointestinal, ophthalmologic, laryngeal, dental, and hematologic problems. This article reviews wound care and management of systemic complications seen in patients with epidermolysis bullosa.

Keratin diseases

The recent discovery that epidermal fragility syndromes can be caused by mutations in the genes for keratin intermediate filaments has been a turning point for research into these structural proteins. Clustering of pathogenic mutations implies differential structural sensitivity along the keratin molecule, and implications for filament function require a new look at culture assay systems, plus a reassessment of structural defects in epithelial and other tissues.